Financhill
Back

Verve Therapeutics Quote, Financials, Valuation and Earnings

Sell
19

VERV
Verve Therapeutics

Last Price:
5.29
Seasonality Move:
35.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Verve Therapeutics Price Quote

$5.29
+0.01 (+0%)
(Updated: June 25, 2024 at 6:19 AM ET)

Verve Therapeutics Key Stats

Sell
19
Verve Therapeutics (VERV) is a Sell

Day range:
$5.20 - $5.49
52-week range:
$4.90 - $21.04
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
23.87
P/B ratio:
0.76%

Volume:
676K
Avg. volume:
1.5M
1-year change:
-71.54%
Market cap:
$443.3M
Revenue:
$11.8M
EPS:
$-2.87

How Much Does Verve Therapeutics Make?

Is Verve Therapeutics Growing As A Company?

  • What Is Verve Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3.06%
  • What Is Verve Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Verve Therapeutics Stock Price Performance

What Is Verve Therapeutics 52-Week High & Low?

Verve Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verve Therapeutics?

Is Verve Therapeutics Cash Flow Positive?

  • What Is VERV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$143.5M
  • What Is Verve Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $233.3M
  • What Is Verve Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$29.3M

Verve Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VERV return on invested capital is -37.6%
  • What Is Verve Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -29.63%
  • What Is VERV Return On Equity?
    ROE is a measure of profitability and is -37.6%

Verve Therapeutics Earnings Date & Stock Price

Verve Therapeutics Competitors

Verve Therapeutics Dividend Yield

Data Unavailable

Verve Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 15.23%
Revenue: 305.63% 153.11%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 26.89
Upside from Last Price: 409.26%

Major Shareholders

  • How many VERV shares are owned by institutional investors?
    115.1M VERV shares are owned by institutional investors
  • How many VERV shares are owned by insiders?
    1.1M VERV shares are owned by insiders